Cantor Fitzgerald Initiates Coverage On Amgen with Overweight Rating, Announces Price Target of $405
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald has initiated coverage on Amgen with an Overweight rating and set a price target of $405.
September 27, 2024 | 2:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald has initiated coverage on Amgen with an Overweight rating and a price target of $405, indicating a positive outlook on the stock.
The initiation of coverage with an Overweight rating and a price target of $405 by Cantor Fitzgerald suggests a positive sentiment towards Amgen's stock. This could lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100